Repetitive Transcranial Magnetic Stimulation (rTMS) in Treatment Resistant Depression: Retrospective Data Analysis from Clinical Practice

Chris Griffiths, Ksenija Da Silva, Robert de Vail, Alex O'Neill-Kerr

Research output: Contribution to JournalArticle

Abstract

Objective:
The aim of this paper is to present the service data results from a clinical repetitive Transcranial Magnetic Stimulation (rTMS) service treating treatment resistant depression (TRD).

Methods
The study was a retrospective investigation of routinely collected data on patients receiving rTMS between 2015 and 2018. Measures used were the clinician-rated Clinical Global Impression (CGI) and Hamilton Depression Rating Scale (HAM-D), and patient rated Physical Health Questionnaire (PHQ-9) and Generalised Anxiety Disorder 7 (GAD-7). The outcome data of 144 patients with TRD was analysed. The sample included patients with co-morbid psychiatric diagnosis.

Results
Response and remission rates respectively were 34.6% and 20.6% for the HAM-D; 10% and 28.6% for the PHQ-9; 31% and 31.8% for the CGI; and 24.6% and 28.8% for GAD-7. Effect sizes were mostly medium (0.48, 0.27, 0.51, 0.43 respectively). GAD-7 reliable change improvement was 56.1% and PHQ-9 reliable change improvement was 40%. There was a medium positive correlation between anxiety (GAD-7) and depression recovery (HAM-D), r = .31, n = 46, p = .039, with lower pre-treatment anxiety associated with lower post-treatment HAM-D scores.

Conclusions
TRD patients with low pre-treatment anxiety levels respond to treatment better than those with high pre-treatment anxiety. The results show that a clinical rTMS service can have a significant impact on symptoms of depression and anxiety in TRD. The findings support wider availability of rTMS as a treatment option for people with TRD.
Original languageEnglish
Pages (from-to)16-28
Number of pages13
Journal Open Journal of Depression
Volume8
Issue number1
DOIs
Publication statusPublished - 17 Jan 2019

Fingerprint

Treatment-Resistant Depressive Disorder
Transcranial Magnetic Stimulation
Anxiety Disorders
Anxiety
Depression
Therapeutics
Mental Disorders
Health

Keywords

  • Repetitive Transcranial Magnetic Stimulation (rTMS)
  • treatment resistant depression
  • service delivery
  • anxiety

Cite this

Griffiths, Chris ; Da Silva, Ksenija ; de Vail, Robert ; O'Neill-Kerr, Alex. / Repetitive Transcranial Magnetic Stimulation (rTMS) in Treatment Resistant Depression : Retrospective Data Analysis from Clinical Practice. In: Open Journal of Depression. 2019 ; Vol. 8, No. 1 . pp. 16-28.
@article{709ff43be9d84f058844b0872223f34f,
title = "Repetitive Transcranial Magnetic Stimulation (rTMS) in Treatment Resistant Depression: Retrospective Data Analysis from Clinical Practice",
abstract = "Objective:The aim of this paper is to present the service data results from a clinical repetitive Transcranial Magnetic Stimulation (rTMS) service treating treatment resistant depression (TRD).MethodsThe study was a retrospective investigation of routinely collected data on patients receiving rTMS between 2015 and 2018. Measures used were the clinician-rated Clinical Global Impression (CGI) and Hamilton Depression Rating Scale (HAM-D), and patient rated Physical Health Questionnaire (PHQ-9) and Generalised Anxiety Disorder 7 (GAD-7). The outcome data of 144 patients with TRD was analysed. The sample included patients with co-morbid psychiatric diagnosis.ResultsResponse and remission rates respectively were 34.6{\%} and 20.6{\%} for the HAM-D; 10{\%} and 28.6{\%} for the PHQ-9; 31{\%} and 31.8{\%} for the CGI; and 24.6{\%} and 28.8{\%} for GAD-7. Effect sizes were mostly medium (0.48, 0.27, 0.51, 0.43 respectively). GAD-7 reliable change improvement was 56.1{\%} and PHQ-9 reliable change improvement was 40{\%}. There was a medium positive correlation between anxiety (GAD-7) and depression recovery (HAM-D), r = .31, n = 46, p = .039, with lower pre-treatment anxiety associated with lower post-treatment HAM-D scores.ConclusionsTRD patients with low pre-treatment anxiety levels respond to treatment better than those with high pre-treatment anxiety. The results show that a clinical rTMS service can have a significant impact on symptoms of depression and anxiety in TRD. The findings support wider availability of rTMS as a treatment option for people with TRD.",
keywords = "Repetitive Transcranial Magnetic Stimulation (rTMS), treatment resistant depression, service delivery, anxiety",
author = "Chris Griffiths and {Da Silva}, Ksenija and {de Vail}, Robert and Alex O'Neill-Kerr",
year = "2019",
month = "1",
day = "17",
doi = "10.4236/ojd.2019.81003",
language = "English",
volume = "8",
pages = "16--28",
journal = "Open Journal of Depression",
issn = "2169-9674",
publisher = "Scientific Research Publishing",
number = "1",

}

Repetitive Transcranial Magnetic Stimulation (rTMS) in Treatment Resistant Depression : Retrospective Data Analysis from Clinical Practice. / Griffiths, Chris; Da Silva, Ksenija; de Vail, Robert; O'Neill-Kerr, Alex.

In: Open Journal of Depression, Vol. 8, No. 1 , 17.01.2019, p. 16-28.

Research output: Contribution to JournalArticle

TY - JOUR

T1 - Repetitive Transcranial Magnetic Stimulation (rTMS) in Treatment Resistant Depression

T2 - Retrospective Data Analysis from Clinical Practice

AU - Griffiths, Chris

AU - Da Silva, Ksenija

AU - de Vail, Robert

AU - O'Neill-Kerr, Alex

PY - 2019/1/17

Y1 - 2019/1/17

N2 - Objective:The aim of this paper is to present the service data results from a clinical repetitive Transcranial Magnetic Stimulation (rTMS) service treating treatment resistant depression (TRD).MethodsThe study was a retrospective investigation of routinely collected data on patients receiving rTMS between 2015 and 2018. Measures used were the clinician-rated Clinical Global Impression (CGI) and Hamilton Depression Rating Scale (HAM-D), and patient rated Physical Health Questionnaire (PHQ-9) and Generalised Anxiety Disorder 7 (GAD-7). The outcome data of 144 patients with TRD was analysed. The sample included patients with co-morbid psychiatric diagnosis.ResultsResponse and remission rates respectively were 34.6% and 20.6% for the HAM-D; 10% and 28.6% for the PHQ-9; 31% and 31.8% for the CGI; and 24.6% and 28.8% for GAD-7. Effect sizes were mostly medium (0.48, 0.27, 0.51, 0.43 respectively). GAD-7 reliable change improvement was 56.1% and PHQ-9 reliable change improvement was 40%. There was a medium positive correlation between anxiety (GAD-7) and depression recovery (HAM-D), r = .31, n = 46, p = .039, with lower pre-treatment anxiety associated with lower post-treatment HAM-D scores.ConclusionsTRD patients with low pre-treatment anxiety levels respond to treatment better than those with high pre-treatment anxiety. The results show that a clinical rTMS service can have a significant impact on symptoms of depression and anxiety in TRD. The findings support wider availability of rTMS as a treatment option for people with TRD.

AB - Objective:The aim of this paper is to present the service data results from a clinical repetitive Transcranial Magnetic Stimulation (rTMS) service treating treatment resistant depression (TRD).MethodsThe study was a retrospective investigation of routinely collected data on patients receiving rTMS between 2015 and 2018. Measures used were the clinician-rated Clinical Global Impression (CGI) and Hamilton Depression Rating Scale (HAM-D), and patient rated Physical Health Questionnaire (PHQ-9) and Generalised Anxiety Disorder 7 (GAD-7). The outcome data of 144 patients with TRD was analysed. The sample included patients with co-morbid psychiatric diagnosis.ResultsResponse and remission rates respectively were 34.6% and 20.6% for the HAM-D; 10% and 28.6% for the PHQ-9; 31% and 31.8% for the CGI; and 24.6% and 28.8% for GAD-7. Effect sizes were mostly medium (0.48, 0.27, 0.51, 0.43 respectively). GAD-7 reliable change improvement was 56.1% and PHQ-9 reliable change improvement was 40%. There was a medium positive correlation between anxiety (GAD-7) and depression recovery (HAM-D), r = .31, n = 46, p = .039, with lower pre-treatment anxiety associated with lower post-treatment HAM-D scores.ConclusionsTRD patients with low pre-treatment anxiety levels respond to treatment better than those with high pre-treatment anxiety. The results show that a clinical rTMS service can have a significant impact on symptoms of depression and anxiety in TRD. The findings support wider availability of rTMS as a treatment option for people with TRD.

KW - Repetitive Transcranial Magnetic Stimulation (rTMS)

KW - treatment resistant depression

KW - service delivery

KW - anxiety

U2 - 10.4236/ojd.2019.81003

DO - 10.4236/ojd.2019.81003

M3 - Article

VL - 8

SP - 16

EP - 28

JO - Open Journal of Depression

JF - Open Journal of Depression

SN - 2169-9674

IS - 1

ER -